Cite
HARVARD Citation
Afzal, M. et al. (2018). Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone. Journal for immunotherapy of cancer. 6 (1), p. . [Online].